Market Overview
Syringe infusion pumps are specialized medical devices that deliver precise, controlled volumes of fluids, medications, or nutrients into a patient's bloodstream over a set period. These devices are widely used in hospitals, ambulatory surgical centers, and home care settings for administering critical drugs such as chemotherapy agents, pain management medications, antibiotics, and parenteral nutrition. The North American segment stands as the dominant regional market globally, with the broader infusion pump market in the region valued at approximately $4.89 billion in 2025.
- •Market valued at approximately $695-701 million in 2025 with a projected CAGR of 8.4-8.8% through 2030
- •Expected to reach around $1.04 billion by 2030
- •North America represents the largest regional share of the global syringe infusion pumps market
Growth Drivers
The rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions across North America is significantly increasing demand for accurate drug delivery systems. An aging demographic profile in the United States and Canada further amplifies the need for reliable infusion technologies in both acute care and long-term treatment settings. Technological advancements in pump safety features, connectivity, and integration with electronic health record systems are also accelerating adoption rates.
- •Growing burden of chronic diseases driving demand for precise medication delivery
- •Aging population increasing requirements for long-term infusion therapies
- •Technological improvements in safety features and digital connectivity
Segmentation and Regional Analysis
The North America syringe infusion pumps market is primarily concentrated in the United States, which accounts for the majority of regional revenue due to its advanced healthcare infrastructure and high healthcare expenditure. Canada represents a smaller but steadily growing segment within the regional market. Product segmentation typically includes large-volume syringe pumps, ambulatory syringe pumps, and specialty pumps designed for specific clinical applications such as neonatal care or analgesia delivery.
- •United States dominates the regional market with the largest share of North American revenue
- •Product categories include large-volume, ambulatory, and specialty application pumps
- •Canada represents a growing secondary market within the regional segment
Trends and Outlook
What are the recent trends and outlook?
The market is expected to continue its upward trajectory through 2030, supported by ongoing healthcare infrastructure investments and the increasing shift toward home-based infusion therapies. Smart pump technology with dose error reduction systems and wireless connectivity is becoming a standard feature in new product offerings across North America. As the market expands beyond $1 billion by the end of the decade, manufacturers are likely to focus on cost-effective solutions and interoperability with hospital information systems to meet evolving clinical and operational requirements.
- •Projected to surpass $1 billion by 2030 based on current growth trajectories
- •Smart pumps with dose error reduction and wireless connectivity are becoming industry standard
- •Growing trend toward home-based infusion care creating new market opportunities
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.